Addictions Management
Articles & Whitepapers
-
CSX-1004: A Promising Canidate in the Fight Against the Fentanyl Crisis
The opioid crisis in the United States is a devastating public health issue, with over 70,000 overdose deaths annually, largely driven by the highly potent synthetic opioid fentanyl. The urgency to address this crisis has spurred the development of innovative therapies to prevent and reverse fentanyl overdoses. In this blog, we will explore the groundbreaking preclinical work on CSX-1004, a fully ...
-
Plethysmography for the assessment of opioid-induced respiratory depression
Opioid-related addiction, overdose and death is a widespread public health crisis. A recent paper published in The Journal of Pharmacology and Experimental Therapeutics by Dr. Renata Marchette ...
News
-
Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference
Positive results confirm findings from prior studies evaluating the abuse potential of cebranopadol, further highlighting its potential as a safe and potent alternative to traditional opioids Registrational phase 3 clinical trials of cebranopadol ...
Leucine-Enkephalin as a Novel Analgesic: Efficacy and Safety in Pre-Clinical Models
Targeting Alternative Opioid Receptor Reduces Drug Side Effects
Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study
Equipment & Solutions
-
Showcase
Nicotine Replacement Polacrilex Gum
Nicotine Replacement Polacrilex Gum. 4 mg (Nicotine) Fruit Freeze. Compare to-. Nicorette® Gum active ingredient.